Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25F6AFE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $243,749
Award facts
- Contract value 100% obligated
- $243,749.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $243,749.25 for Stelara 90 mg/ml syringes by the Defense Logistics Agency's Medical Supply Chain division on September 8, 2025. This delivery order, with an ultimate completion date of September 29, 2025, carries no set-aside designation and represents a standard procurement action under the company's existing Indefinite Delivery Contract with the DLA. The award reflects DMS Pharmaceutical Group's established role as a critical supplier of pharmaceutical products to Department of Defense healthcare facilities nationwide.
This delivery order is issued under DMS Pharmaceutical Group's substantial single-award IDC with the DLA valued at $499,999,999 and extending through November 2026. The parent contract, administered under the SPE2DB program, authorizes firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical items, including branded and generic prescription drugs, biologics, and medical consumables serving military health facilities worldwide. Stelara, a biologic immunosuppressant medication, exemplifies the specialized pharmaceutical products the contractor routinely supplies through this vehicle to support the medical supply needs of the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DX25F6AFE?
SPE2DX25F6AFE was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 8, 2025.
How much is contract SPE2DX25F6AFE worth?
The government has obligated $243,749 on SPE2DX25F6AFE.
Is contract SPE2DX25F6AFE an order under another contract?
Yes. SPE2DX25F6AFE is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AFE competed?
The extent of competition for SPE2DX25F6AFE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award